drugset
drugset / Trial / NCT01477424

A Drug-Drug Interaction Study of Warfarin and PA21

NCT01477424 ↗

Phase 1 Completed 45 enrolled Vifor Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine if Warfarin is affected by PA21.

Timeline

Start
2011-11
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PA21 Unknown 15 g —
Subject Warfarin Small molecule 10 mg —

Indications

No indication recorded.